FDA Is Now an Open Book: RFK Jr. Forces FDA Into the Open

What Happened

In an effort to push for “radical transparency,” U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has endorsed a significant change in how the Food and Drug Administration (FDA) manages drug and vaccine safety data.

Moving forward, the FDA will begin releasing adverse event reports in real time through its Adverse Event Reporting System (FAERS). Previously, these reports, which documented side effects and other negative outcomes from medications, vaccines, and biologics, were batched and published quarterly. Now, updates will be both immediate and publicly accessible.

The change is spearheaded by FDA Commissioner Dr. Marty Makary, a vocal advocate for overhauling the agency’s data infrastructure. Makary cited outdated reporting systems, bureaucratic lag, and a lack of transparency as major roadblocks to public trust.

RFK Jr. is no stranger to making headlines. He recently disbanded and reconstituted the vaccine advisory committee (ACIP), which has long been criticized for perceived conflicts of interest. The FDA’s new policy will now be part of a larger initiative to modernize drug safety oversight, with the goal of regaining public confidence in medical institutions.

Why It Matters

The FDA’s move reflects a growing demand for accountability in public health. The agency’s handling of data, particularly around vaccine injuries or adverse drug reactions, has been opaque, delayed, or selectively communicated. A lack of real-time transparency has fueled speculation and eroded public trust.

You’re feeding AI for free. Why?

The hidden fuel behind AI? Your phone.

You spend hours on your phone — scrolling, searching, tapping…And all that data?

It trains AI systems, improves algorithms, and powers breakthroughs. But who’s getting paid?

Not you.

Not yet.

Mode Mobile figured out how to turn this data flow into cash flow, and they’re rewarding users for the exact same behavior that Big Tech exploits for free.*

They’re building a user-powered data economy that shares the upside and earned the #1 spot on Deloitte’s 2023 list of fastest-growing software companies.

Mode Mobile already has:

● 50M+ users from 170+ countries
● $325M+ earned and saved by users
● 32,481% revenue growth
● Nasdaq ticker secured ($MODE)

All before ever going public.

And now investors can grab pre-IPO shares at just $0.30/share

AI is the future, but your phone’s been the fuel all along.

Now’s your chance to own the pump but not for long as final allocations are disappearing quickly.

🚨Round closing — invest at 0.30/share now.

Real-time FAERS updates could change that. By removing the months-long lag between incident reports and public access, the FDA is inviting independent researchers, journalists, and ordinary citizens to scrutinize data without gatekeeping.

Dr. Makary framed the change as a move to empower the public with timely, unfiltered information. He argued that making safety data instantly accessible allows people to make more informed decisions about their health, without relying solely on filtered agency reports or media coverage.

From a policy angle, RFK’s push for transparency aligns with his wider agenda of health freedom, holding corporations accountable, and overhauling institutions. Whether his approach seems disruptive or forward-thinking, he is clearly challenging the status quo.

How It Affects Readers

Real-time FAERS access means individuals can now track adverse events tied to specific medications as they’re reported. There’s no longer a need to wait for quarterly summaries or dig through red tape.

For example, if a drug you or a loved one uses starts showing a spike in negative reports, you’ll be able to see that trend as it develops. That’s a potential game-changer for personal healthcare decisions.

It also opens up a dialogue between patients and healthcare providers. Armed with up-to-date safety data, patients can ask more informed questions and challenge assumptions, particularly when starting new treatments.

The ability to analyze live data without needing internal FDA clearance democratizes oversight. It could lead to quicker identification of harmful trends, possibly even before the agency issues formal alerts. RFK’s decision strips away bureaucracy and puts vital safety information directly into the hands of the public.

In a time when trust in institutions is fragile, real-time reporting might be the clearest path to rebuilding it.

*Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.

The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.

Please read the offering circular and related risks at invest.modemobile.com.